Anti-RSV G protein antibodies
US9321830B2 · kind B2 · utility
1Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2012 |
| Grant date | Apr 26, 2016 |
| Priority date | — |
| Expiry date | Aug 9, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/11011
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Individual monoclonal antibodies and fragments that bind a conserved epitope of the G protein of RSV and which are minimally immunogenic when administered to a human subject, are useful in treating RSV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.